Incorporating Correlation in Interindividual Variability for the Optimal Design of Multiresponse Pharmacokinetic Experiments

This paper presents a method for optimal design of multiresponse population pharmacokinetic experiments taking into account correlations between interindividual variances. Expressions for the population Fisher information matrix have been defined for uniresponse and multiresponse pharmacokinetic experiments. A major assumption often made is that the variance–covariance matrix of the interindividual variance components has only diagonal elements so that whenever intersubject covariance elements are present, they are ignored during the design of the experiment. Recently expressions that accounted for these off diagonal elements were developed for uniresponse population pharmacokinetic experiments. The work presented here extends these expressions to multiresponse population pharmacokinetic experiments. These were applied to a population pharmacokinetic model, a population pharmacokinetic–pharmacodynamic model, and a parent–metabolite pharmacokinetic model example. The results obtained showed that optimal designs are different with diagonal omega matrix and full omega matrix and ignoring the off diagonal elements can lead to a design that produces more biased and less precise parameter estimates compared to a design that includes the off diagonal elements. The results also showed correlation between residual components of the responses has an effect on the optimal design.

[1]  W. J. Studden,et al.  Theory Of Optimal Experiments , 1972 .

[2]  Gordon Graham,et al.  A program for individual and population optimal design for univariate and multivariate response pharmacokinetic-pharmacodynamic models , 2007, Comput. Methods Programs Biomed..

[3]  France Mentré,et al.  Fisher information matrix for non‐linear mixed‐effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics , 2002, Statistics in medicine.

[4]  Leon Aarons,et al.  Optimum blood sampling time windows for parameter estimation in population pharmacokinetic experiments , 2006, Statistics in medicine.

[5]  Lewis B. Sheiner,et al.  Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects , 1992, Journal of Pharmacokinetics and Biopharmaceutics.

[6]  France Mentré,et al.  Optimization of Individual and Population Designs Using Splus , 2003, Journal of Pharmacokinetics and Pharmacodynamics.

[7]  Malcolm Rowland,et al.  Optimal Design for Multivariate Response Pharmacokinetic Models , 2006, Journal of Pharmacokinetics and Pharmacodynamics.

[8]  Gordon Graham,et al.  Optimal Design for Multiresponse Pharmacokinetic–Pharmacodynamic Models – Dealing with Unbalanced Designs , 2007, Journal of Pharmacokinetics and Pharmacodynamics.

[9]  Brian Whiting,et al.  Experimental design and efficient parameter estimation in population pharmacokinetics , 1990, Journal of Pharmacokinetics and Biopharmaceutics.

[10]  Gordon Graham,et al.  The use of a modified Fedorov exchange algorithm to optimise sampling times for population pharmacokinetic experiments , 2005, Comput. Methods Programs Biomed..

[11]  J. Schellens,et al.  Development of an optimal pharmacokinetic sampling schedule for rubitecan administered orally in a daily times five schedule , 2002, Cancer Chemotherapy and Pharmacology.

[12]  France Mentré,et al.  Further Developments of the Fisher Information Matrix in Nonlinear Mixed Effects Models with Evaluation in Population Pharmacokinetics , 2003, Journal of biopharmaceutical statistics.

[13]  Stephen B. Duffull,et al.  The use of simulated annealing for finding optimal population designs , 2002, Comput. Methods Programs Biomed..

[14]  Sergei Leonov,et al.  OPTIMAL POPULATION DESIGNS FOR PK MODELS WITH SERIAL SAMPLING , 2004, Journal of biopharmaceutical statistics.

[15]  Paolo Vicini,et al.  Simultaneous population optimal design for pharmacokinetic-pharmacodynamic experiments , 2005, The AAPS Journal.

[16]  Alain Mallet,et al.  Optimal design in random-effects regression models , 1997 .

[17]  Stephen B. Duffull,et al.  Optimal Design for Model Discrimination and Parameter Estimation for Itraconazole Population Pharmacokinetics in Cystic Fibrosis Patients , 2005, Journal of Pharmacokinetics and Pharmacodynamics.

[18]  M. Foracchia,et al.  POPED, a software for optimal experiment design in population kinetics , 2004, Comput. Methods Programs Biomed..

[19]  France Mentré,et al.  Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs , 2001, Comput. Methods Programs Biomed..

[20]  W. G. Hunter,et al.  Design of experiments for parameter estimation in multiresponse situations , 1966 .